1. Favia G, Lumachi F, Polistina F, D’Amico D.
Pheochromocytoma, a rare cause of hypertension: Longterm
follow-up of 55 surgically treated patients.
Endocrine Surgery Un it, Clinica Chirurgica I, University
of Padua; via Giustiniani 2, 35128 Padua, Italy. World J
Surg, 1998; 22: 689-93.
2. Esener Z. ‘Klinik Anestezi’ logos yayıncılık. Samsun
1997; 306-307.
3. Shulutter J, Westhofen P, Kania U, Ihmsen H,
Kammerecker S, Hirner A. Quantitative assessment of
cathecolamine secretion as a rational principle of
anesthesia management in pheochromocytoma surgery.
Anasthesiol Intensivmed Notfallmed Schmerzther 1995;
30: 341-9.
4. Mason RA. Anaesthesia Databook: A clinical Practice
Compendium 2nd Ed. London, Churchill Livingstone
1994; 354.
5. Rozien MF. Diseases of the Endocrine System. In
Benumof J, ed Anesthesia and uncommen diseases 4th
ed. Philadelphia WB Saunders Company1998; 257-9.
6. Mark BJ, Slaughter TF, Reves JG. Cardiovascular
monitoring. In Anesthesia ed Miller RD. Churchill
Livinstone, Philadelphia, USA 2000; 1125.
7. Opie LH. ‘Kardiyolojik İlaçlar’ Nobel Tıp Kitabevi, 4.
Baskı 1996; 3: 53-87.
8. Munro J, Hurlbert BJ, Hill GE. Calcium channel
blockade and uncontrelled blood pressure during
pheochromocytoma surgery. Can J Anesth 1995; 42: 228-
30.
9. Takahashi K, Hirata K, Tanaka M, Shigemori S, Sai Y,
Nosaka S. Anesthetic management of a child with
pheochromocytoma using sevoflurane, diltiazem and
continuous epidural blockade. Masui (abstract) 1996; 45:
1252-5.
10. Fujiwara M, Zaha M, Odashiro M, Kawamura J, Hayashi
I, Mizaguchi H. Use of diltiazem in the anesthetic
management of epinephrine predominant
pheochromocytoma. Masui (abstract) 1992; 41: 1175-9
